Neurology
News from the FDA/CDC
Stewart Tepper: Emgality approval ‘very exciting’
The treatment binds to calcitonin gene-related peptide and is the first therapy to reduce the frequency of episodic cluster headache attacks.
Conference Coverage
DOACs surpass warfarin in low-weight AFib patients
SAN FRANCISCO – Data from 21,000 Korean AFib patients weighing 60 kg or less showed DOACs had better efficacy and safety than did warfarin.
Conference Coverage
Meta-analysis finds no link between PPI use and risk of dementia
SAN DIEGO – In the absence of randomized trial evidence, a PPI prescribing approach based on appropriate use appears sufficient.
CE/CME
Click for Credit: Biomarkers for VTE risk; Exercise & concussion recovery; more
Topics include: No 1 tx for fibromyalgia • Mood & behavior in kids • Biomarkers for VTE risk • Exercise & concussion recovery • Survival...
Conference Coverage
Low baseline heart rate may not increase cardiac risk when starting fingolimod
SEATTLE – First-dose cardiac events with fingolimod are rare, regardless of whether first-dose observations occur in clinic or at home.
News
Questions remain as marijuana enters clinic use
SAN FRANCISCO – It’s best to ask people what they’re using, and to counsel new users – especially the elderly – to start low and go slow, Dr....
Conference Coverage
Hazardous cannabis use in MS linked to anxiety, depression
SEATTLE – But it is not clear if there is a cause-and-effect relationship.
News
Periodic limb movements during sleep are common in patients with MS and fatigue
SEATTLE – Sleep apnea may not be the only comorbidity that causes fatigue in multiple sclerosis, and treating...
Conference Coverage
Pain, fatigue, depression, and anxiety are common in the year after MS diagnosis
SEATTLE – In a novel study, about half of patients with multiple sclerosis reported clinically significant symptoms of depression or pain, and...
Conference Coverage
Age may influence choice of behavioral therapy to improve sleep in MS
SEATTLE – Few studies have examined the relationships between physical activity, sedentary behavior, and sleep...